Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines
摘要:
In preceding communications we summarized our medicinal chemistry efforts leading to the identification of potent, selective, and orally active S1P(1) agonists such as the thiophene derivative 1. As a continuation of these efforts, we replaced the thiophene in 1 by a 2-, 3-, or 4-pyridine and obtained less lipophilic, potent, and selective S1P(1) agonists (e.g., 2) efficiently reducing blood lymphocyte count in the rat. Structural features influencing the compounds' receptor affinity profile and pharmacokinetics are discussed. In addition, the ability to penetrate brain tissue has been studied for several compounds. As a typical example for these pyridine based S1P(1) agonists, compound 53 showed EC50 values of 0.6 and 352 nM for the S1P(1), and S1P(3) receptor, respectively, displayed favorable PK properties, and penetrated well into brain tissue. In the rat, compound 53 maximally reduced the blood lymphocyte count for at least 24 h after oral dosing of 3 mg/kg.
DOI:
10.1021/jm4014696
作为产物:
描述:
5,6-二氯烟酸 、 异丙醇 在
1,4-二氧六环 、 crude product 、 ethyl acetate heptane 作用下,
以
硫酸 为溶剂,
反应 16.0h,
以to give 5,6-dichloro nicotinic acid isopropyl ester (9.29 g) as a pale beige oil的产率得到5,6-dichloronicotinic acid isopropyl ester
PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS
申请人:Bolli Martin
公开号:US20110212998A1
公开(公告)日:2011-09-01
The invention relates to novel pyridine derivatives of formula (D, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituents are as defined in the claims.
[EN] PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS DE PYRIDINE
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2009024905A1
公开(公告)日:2009-02-26
The invention relates to novel pyridine derivatives of formula (I), their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituants are as defined in the claims.
[EN] PYRIDINE COMPOUNDS<br/>[FR] COMPOSÉS DE PYRIDINE
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2009109906A1
公开(公告)日:2009-09-11
The invention relates to pyridine compounds, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
这项发明涉及吡啶化合物,它们的制备以及它们作为药用活性化合物的用途。这些化合物特别作为免疫调节剂。
PTERIDINES AND THEIR USE AS AGROCHEMICALS
申请人:Brewster William K.
公开号:US20110054173A1
公开(公告)日:2011-03-03
The present disclosure relates to 1- or 2-(4-(aryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and 1- or 2-(4-(heteroaryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and their use as agrochemicals and animal health products.
2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamides with carboxylic
申请人:Dow AgroSciences LLC
公开号:US05968875A1
公开(公告)日:1999-10-19
The present invention provides novel 2-methoximino-2-(pyridinyloxymethyl)phenyl acetamide compounds with carboxylic acid substituents on the pyridine ring, their use as fungicidal compounds, and their use in fungicidal compositions comprising at least one of the 2-methoximino-2-(pyridinyloxymethyl)phenyl acetamide compounds as the active ingredient.